Home / Companies / Results / Sun Pharma posts surprise Rs 2,184 cr Q1 pre-tax loss on one-time expense

Sun Pharma posts surprise Rs 2,184 cr Q1 pre-tax loss on one-time expense

Firm's US revenue dips 33.5%; one-time loss of Rs 3,633 cr pertains to $213.3 mn pzayment by Taro, a Sun Pharma subsidiary, for settlement of anti-trust cases in the US

Sun Pharma Founder and Managing Director Dilip Shanghvi said the company would grow its speciality drug pipeline globally and expand manufacturing facilities

Premium

Sun Pharma posted a loss before tax of Rs 2,183.9 crore as compared to a profit before tax of Rs 1,647.4 crore in the corresponding quarter previous year.

Sohini Das Mumbai

3 min read Last Updated : Aug 01 2020 | 1:28 AM IST

Sun Pharmaceutical Industries, the country’s largest drugmaker, reported a surprise loss in the first quarter hit by one-time charges. The company’s US business posted a 33.5 per cent decline during the quarter, while India sales were up 3.2 per cent on a year-on-year (YoY) basis. Consolidated sales from operations at Rs 7,467 crore, a decline of about 9.6 per cent over same quarter last year.

Sun Pharma posted a loss before tax of Rs 2,183.9 crore, as compared to a profit before tax of Rs 1,647.4 crore in the corresponding quarter previous year.

The firm posted a net loss of Rs 1,655

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in